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The Business Project was centered on the launch of a Vichy Dercos Neogenic product 
and two main issues were addressed. Firstly, the group conducted a Market Analysis 
and a Target Definition exercise, bearing in mind the possible cannibalization effect on 
revenues of previous products. Secondly, a 360º Launch Strategy was devised, focusing 
on every touchpoint of the consumer journey. Within the scope of this Work Project, the 
product innovation process conducted by Vichy was framed as an investment 
opportunity incorporating real options and accounting for technological and market 
uncertainty, leading to a more accurate Net Present Value of the project. 
Key Words: Target Definition, Launch Strategy, Investment Opportunity, Real Option  
  




TABLE OF CONTENTS 
 
Abstract ............................................................................................................................. 2 
1. The Business Project – Description and Challenge .................................................. 4 
a. L’Oréal Group ....................................................................................................... 4 
b. Vichy ..................................................................................................................... 4 
c. Current Client Situation  – Vichy Italia and Dercos Neogenic ............................. 5 
d. The Business Project Challenge ............................................................................ 5 
2. Reflection on the Work Done.................................................................................... 5 
a. Problem Definition ................................................................................................ 5 
b. Methodology of the Business Project .................................................................... 6 
i. Hypothesis and Initial Considerations ............................................................... 6 
ii. Work Plan and Project Structure ....................................................................... 8 
iii. Analysis ............................................................................................................. 8 
c. Conclusions and Recommendations .................................................................... 11 
d. Implementation and Concerns ............................................................................. 14 
3. Product Launch as an Investment Opportunity ....................................................... 15 
a. Theoretical Framework – NPV and Real Options ............................................... 15 
b. Product Innovation and Launch – Investment Timeline ..................................... 16 
c. Mapping Vichy Dercos Neogenic Gel-Fluid as an Investment ........................... 17 
i. Compute Base Case PV – No Flexibility ......................................................... 18 
ii. Model Uncertainty ........................................................................................... 19 
iii. Incorporate Managerial Flexibilities – Real Options ....................................... 20 
iv. Calculate Real Option Value ........................................................................... 22 
d. Current Situation and Investment Decision ......................................................... 24 
4. Bibliography ............................................................................................................ 25 
5. Acknowledgements ................................................................................................. 25 
 
  




1. THE BUSINESS PROJECT – DESCRIPTION AND CHALLENGE 
a. L’ORÉAL GROUP 
A French cosmetics company operating in 130 countries, L’Oréal is the irrefutable 
global market leader when it comes to beauty care. Founded in 1909 by Eugène 
Schueller, it experienced a period of fantastic growth due to strategic acquisitions and 
international expansion between 1957 and 1983. During this period, L’Oréal created 
emblematic products such as Elnett and Kérastase. It also acquired Lâncome, Garnier, 
Biotherm and Vichy. There are five divisions: L’Oréal Luxe (Cacharel, YSL Beauté, 
Ralph Lauren Fragrances, etc.), Active Cosmetics (Vichy, La Roche-Posay, 
SkinCeuticals, etc.), Consumer Products (L’Oréal Paris, Maybelline New York, 
Garnier, etc.), The Body Shop and Professional Products (L’Oréal Professionnel, 
Kérastase, Redken, etc.). In 2014, the Group had consolidated sales of 22.53 billion 
euro and the Active Cosmetics division sold 1,660.4 million euro with 77.5% of these 
sales being related to skincare products and the majority being attributable to Vichy. 
b. VICHY 
Vichy is a city in the center of France which is globally known for its mineral-rich, 
Thermal Spa Water. Back in 1931, Dr. Prosper Haller, a medical director at the thermal 
treatment center in that same city uncovered the therapeutic virtues of Vichy Thermal 
Spa Water on the skin – such as improving skin quality, soothing sensitivity and 
accelerating wound healing. Convinced of having found a business idea with 
tremendous potential, Dr. Haller created the first line of skincare cosmetics, having 
Vichy Thermal Spa Water at the core of every formulation. 
From then on, Vichy has always been at the forefront of innovation, heavily investing in 
R&D and combining the idea of beauty care intrinsically with that of healthcare, 
creating a unique value proposition that is still strongly embedded in the brand. Even 
though the main focus of the brand is skincare, other products exist within the beauty 
and healthcare sectors. The brand’s products are mostly sold in pharmacies, a fact that 
motivated L’Oréal to start cooperating with Vichy in 1954, granting the beauty care 
giant a better control of this specific distribution channel. L’Oréal integrated Vichy in 
its brand portfolio definitively in 1980. 




c. CURRENT CLIENT SITUATION  – VICHY ITALIA AND DERCOS NEOGENIC 
In Italy and as of 2014, L’Oréal’s Active Cosmetics Division was leading the 
dermocosmetics industry with 14.3% market share, placing itself ahead of Pierre Fabre 
(10.5%) or Bionike (6.1%). More specifically, Vichy Italia presented in the last year a 
turnover of 60 million euro and it was the leader in pharmacy sales, having an 8.4% 
market share and boasting its image as a “healthy chic” pharmacy brand. One of the 
strategic markets within which Vichy Italia operates is the anti-hair loss business. 
Overall, this industry represents a 90 million euro turnover in Italy, whereas 50 million 
are obtained through pharmacies and 30.2 million through hair salons. In order to tackle 
this important market, Vichy has created two Dercos product lines.  
On one hand, there is Dercos Aminexil Pro, which is sold in two gender-differentiated 
versions of 30 ampoules at a price of 81 euro. For intensive action, one ampoule per day 
must be applied on the scalp and must be distributed evenly, during 10 minutes, leaving 
it to take effect without rinsing. Dercos Aminexil Pro is designed to tackle seasonal hair 
loss and to accelerate stronger hair growth.  
On the other hand, Dercos Neogenic is sold as a pack of 28 ampoules, which costs 
99,90 euro and the consumer must use an ampoule per day, every day, during 3 
consecutive months. Upon placing the product on one’s scalp, it is then necessary to 
massage it so that the product gets absorbed. This process takes around 10 minutes. 
Vichy communicates abundantly that this product does not cure severe baldness but 
helps in stimulating hair growth by awakening bulbs which have been dormant.  
d. THE BUSINESS PROJECT CHALLENGE 
Within this context, the challenge that was presented to the group was to develop 
strategic recommendations to position, launch and sell a new version of the Dercos 
Neogenic category without cannibalizing the sales of the existing product.  
2. REFLECTION ON THE WORK DONE 
a. PROBLEM DEFINITION 
In the past year, the anti-hair loss market has been shrinking due to the economic crisis 
and the damaged credibility of the products. This has affected the top three industry 




players – Vichy, Giuliani and Idi. In the first semester of 2015, Vichy sought to restore 
the credibility back to the market, creating the first national hair and scalp health 
prevention campaign, where customers would go to one of the 3,000 pharmacies 
involved and would get a free check-up.  
Vichy then started pondering its next steps, specifically regarding its Dercos Neogenic 
product. Through a survey made in the Italian, French and Spanish markets, the 
company found out that the main issues of its product were that 60% of people stop the 
treatment before completion (3 months), 39% think it is too expensive, 26% say the 
results are not visible and 18% say that the product is not practical. Vichy also believed 
that by solving the latter three problems, it could solve the issue of treatment 
abandonment. To address the price issue, the company was creating a loyalty card and 
to tackle the problem of results lacking, Vichy was committed to better targeting its 
consumers and to create a 3 months coaching motivation mechanism. 
However, the practicality of usage was still a challenge. The key consumer insights 
regarding this issue were that the application time was too long (24%) and that it made 
the hair too wet (10%), being even more problematic when applied in the morning 
(which was what 37% of the consumers did). So in this case, the solution that Vichy 
adopted was to launch a gel-fluid version of the Dercos Neogenic product, as opposed 
to the existing liquid format. 
Bearing all of the above in mind, the task that Vichy assigned to the group required 
answers to three key points. First, it was necessary to deeply understand what 
positioning to give to this new product and who to target. Secondly, it was essential to 
take into consideration the possible cannibalization of revenues of the existing Dercos 
Neogenic product and to make plans to minimize this effect. Finally, Vichy required a 
360º launch strategy, with recommendations for all possible customer touchpoints. 
b. METHODOLOGY OF THE BUSINESS PROJECT 
i. Hypothesis and Initial Considerations 
At the center of this Business Project was the hypothesis that launching a new gel-fluid 
Dercos Neogenic would lead to increased practicality of usage of the product and 
consequent consumer satisfaction, complementarity with the existing product – which 
could lead to improved targeting –, a decrease in the abandonment rate of treatments, a 




rise of visible results and, finally, larger sales revenues from increased referrals and 
augmented credibility. Vichy therefore saw the launch of the new product as a 
cornerstone in its strategy for turning around the anti-hair loss product and that was 
exactly what needed to be done through this launch. 
In terms of the considerations that were needed to kick-off the Business Project, there 
were four essential ones that were discussed with Vichy and were taken as a given 
throughout the entirety of the project. Firstly, given the strategic importance of the 
product launch at hand, Vichy stated that there were to be no budget constraints on this 
project. Even though Vichy had a number in mind, the company did not wish to disclose 
it. However, the company did say that the budgeted values were very high given the 
potential that the launch had to grow the market and the intrinsic profitability of the 
anti-hair loss market and of its Dercos product line. This gave way for all creative and 
effective ideas to be presented, regardless of their cost of implementation.  
Secondly, Vichy stated that it would give no further information to the group regarding 
market analysis, consumer insights or their beliefs in terms of who to target for the new 
gel-fluid Dercos Neogenic. With this measure, the company aimed to have a Business 
Project that was totally unbiased by Vichy’s generalized opinion, opening a door for 
views which might be simultaneously different from theirs and more adequate.  
Thirdly, the group was told that the target which was previously assigned to the existing 
Dercos Neogenic product was merely defined as “those who experience hair thinning 
and receding hairlines”. No further specifications regarding demographic or 
psychographic factors were made, creating a very disperse customer base. Therefore, if 
the gel-fluid version was to be launched and properly targeted, the Business Project 
would also have to suggest a repositioning of the liquid version, so as to not confuse 
consumers and to minimize cannibalization. 
Finally, it was necessary to perfectly grasp the differences between the two Dercos 
Neogenic versions. Both products have the exact same efficacy. The only difference 
concerns the application method. However, it is necessary to communicate this to 
consumers, avoiding that they believe the gel-fluid product to be an updated and 
improved version of the liquid product. 




ii. Work Plan and Project Structure 
Upon discussing with Vichy and the Academic Advisor, Professor Emanuela Prandelli, 
a clear-cut approach was designed in order to better proceed with the Business Project. 
The group would start by focusing on coming up with an ideal positioning for the new 
product, recurring to any kind of analysis that it deemed necessary. After having 
extracted relevant conclusions from this analysis, an intermediate meeting and 
presentation would be held halfway along the semester between all involved parties to 
present the findings, get feedback from Vichy on the quality of the work and the target 
choice and approval to keep working on this target or to keep searching for a better one.  
After getting the approval, the group would then delve into the details of creating the 
360º launch strategy with the most innovative ideas possible while keeping the end 
goals of the Business Project in mind. The work plan would then culminate with a final 
presentation where the launch strategy would be explained to Vichy in detail, clarifying 
the reason behind every action and how and when each of them should take place. 
iii. Analysis 
1. Market Analysis and Target Definition 
In order to better understand the anti-hair loss market and to be able to decide on the 
best possible positioning for the new gel-fluid Dercos Neogenic product, the group 
decided to adopt a methodology based on the analysis of three different dimensions or 
stakeholder groups: Consumers, Competitors and Distributors. 
Regarding the Consumer Analysis, three different methods were employed. Firstly, by 
using online tools such as SocialMention or Google Blog Search, consumers’ opinions 
about Dercos Neogenic could be grouped and analyzed but none of the tools proved to 
be too effective in providing enough data to extract valuable conclusions from. The 
second method used was the analysis of Dercos Neogenic feedback on Beauté Test, an 
online database where French consumers write their reviews about beauty and health 
care products, describing strengths and weaknesses and rating each product 
characteristics, as well as leaving some of their demographic data.  
Resorting to this database of 94 observations at the time of the analysis and removing 
all extreme observations – ratings of 5 stars or 1 star to every single characteristic – and 
collecting all the data in a table, it was possible to extract some conclusions. 




Since women in age ranges between 25 and 45 years old are the most abundant 
population in this sample (54.25%), it was assumed that all results extracted from this 
subset of the data would be closer to statistical significance, even if these subsamples 
were still too small to approach their distribution to a normal one. An interesting result 
was that older women seem to be, overall, more satisfied with the product. 
 
Even when focusing strictly on Global Sentiment and creating a weighted average, 
accounting for several hypotheses, such as changing price sensitivity and evolving 
appreciation for different product features such as texture and smell, this difference 
seemed to persist.  
 
A final and particularly important result extracted from this database was the fact that 
21.3% of the entire sample were actually complaining that the product was “too liquid” 
and 85% of those complaints were coming from women between 25 and 50 years old. 
Even if these five age ranges of women represent 60.64% of the entire sample, it can be 
seen that they become an even more relevant group when it comes to complaining about 
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Graph 1 – Beauté Test Ratings (BTR): Women Aged 25- 45 

















The last method employed was the analysis of the TRND Italian Panel with 500 
consumers being chosen to try the product for free during 3 months. Besides the fact 
that consumers were satisfied with the product, the most important insight was that most 
consumers used Dercos Neogenic in the evening, before going to bed. 
Going on to the Competitors Analysis, the group decided to investigate which solutions 
for permanent hair loss were available in the Italian market. There were two main 
competitors: Bioscalin and Phyto. Both had two different product lines for addressing 
this issue, targeted by gender: Bioscalin Intensiv and Phyto’s Phytolium for men and 
Bioscalin Tricoage+ and Phyto’s Phytocyane for women. It was also clear that 
competitors had three different product categories: Vials (such as the existing Dercos 
Neogenic), Shampoos and Oral Complements. Vials are seen as the most effective 
method, but also the most expensive, by consumers. Oral complements, on the other 
hand, seem to have a better quality/price relationship, at least in the eyes of the 
consumers, and are therefore often preferred to vials.  
Finally, concerning the Distributors Analysis, the group chose two distinct methods to 
gather insights. Firstly, face-to-face interviews with 16 different pharmacies in Como 
and Milan were performed to understand the customers’ attitude towards anti-hair loss 
products, the pharmacists’ perception of Dercos’ strengths and weaknesses and their 
opinions regarding the gel solution. During these interviews, the pharmacists agreed that 
customers who finalized the purchase are committed with finishing the treatment. 
However, many potential clients are lost due to the high price of the product and the 
complexity and invasiveness of the treatment. The gel-fluid version of Dercos Neogenic 
would address this second issue, but pharmacists showed some skepticism regarding 
this new format, stating that Vichy would have to clearly communicate the benefits of 
the product and to debunk some beliefs such as that of the gel making hair greasier. 
On the other hand, a mystery shopping activity was developed, targeting 12 other 
pharmacies in Milan and Ancona, to identify the results of the existing training sessions 
that Vichy held for pharmacists regarding its anti-hair loss products, grasping how much 
they knew about the product. The group discovered that less than half of the pharmacies 
were aware of the right purpose of Neogenic. These pharmacies were also the only ones 
who knew the dosage. Nevertheless, all of them were sure of the quality of Neogenic. 




Taking into consideration the three analyses and its results, it was possible to extract 
some conclusions that allowed the group to identify what would be the ideal target for 
the new Vichy Dercos Neogenic product and how to reposition the existing product. 
2. 360º Launch Strategy 
Concerning the Launch Strategy, there was a set of challenges to be addressed. These 
challenges, specific to the new Dercos Neogenic product launch were to avoid 
cannibalization, to increase awareness and perceived added value, to tackle the 
invasiveness issue, to fight skepticism regarding the gel version and to increase 
customer retention by recommending the right treatment.  









Taking into consideration the analyses performed, there were several key takeaways 
extracted, which were then fundamental for the target definition exercise, as shown 
above. Hence, the target population for the new gel-fluid format was defined as “active 
timesavers, professional people on-the-go, who prefer easier and quicker solutions and 
who have dry cutis”. This lead the group to reposition the existing liquid format product 
towards a target that included older men and women who are less active and have a 
fatter cutis. Also, the group decided to differentiate the products based on the occasion 
of use – Dercos Neogenic liquid would be dedicated to a more relaxed evening beauty 
routine and Dercos Neogenic gel-fluid being associated to the morning routine.  
Figure 1 – Market Analysis Takeaways and Possible Targets 




In considering the launch strategy, it is necessary to communicate on both products and 
to highlight the different occasions of use and application, while stressing the exact 
same efficacy. Also, the 360º launch strategy was divided into six key issues and 
recommendations: Pharma (Distributors) Strategy, Public Relations Event, Media 
Strategy, Pop-up Stores, In-Pharmacy Experience and the Mobile App. 
The developed Pharma Strategy focused on recommendations for educating pharmacists 
and for restructuring their incentive system. On the first point, the group developed an 
innovative training day, starting with a presentation about all the products of the Dercos 
category, highlighting its virtues and differences. Afterwards, a gamification element 
was introduced – “MillionHair” – which would be used as a way to check pharmacists’ 
knowledge of the product mixed with fun hair trivia, with the best performers being 
rewarded. The day would continue with a Discovery session with different booths 
where pharmacists could get to know the Dercos App, try the gel-fluid product 
themselves and be convinced of the texture of the new version or ask specific questions 
about their issues with the product. Finally, the day would conclude with a networking 
dinner consisting of food that improves hair health such as fish, eggs, chicken and 
spices like cumin or black pepper. On the restructuring of the incentive system for 
pharmacists, the main goal is to motivate more accurate product recommendations, 
higher customer satisfaction and lower treatment abandonment rate. This would be done 
by introducing Dercos Points with a multiplier effect (e.g. 100 points for a single 
package sold and 600 points for a complete treatment of 3 packages sold to the same 
customer) which pharmacists could then exchange for rewards. The Dercos Points 
system would allow, as a side effect, the tracking of each individual client’s purchase 
history and a more comprehensive customer database. 
In terms of the Public Relations Event, it should be targeted to key opinion leaders such 
as press agents, beauty bloggers and medical experts, achieving mentions in press and 
online and increasing awareness of the Dercos product line. The event would start with 
a molecular cuisine lunch, going on to a presentation, a hair diagnosis of the guests with 
the recommendation of a Dercos product, a “show house” reflecting the two sided story 
of two different occasions of use, two different products and one standard of excellent 
efficacy. Then, the guests would go to the “hairdresser corner” where they would be 
given a free haircut and styling with L’Oréal products, before finishing the night off 




with a party in La Rotonda della Besana in Milan, where the guests would be joined by 
the partner pharmacists (i.e. the ones who attended the training day). 
Regarding the Media Strategy, there would be more targeted advertising for the gel- 






In addition, an interactive advertising through digital channels would be created, very 
similar to that of Honda Civic Type R, where viewers can click “R” on the keyboard to 
change between the sides of the double-sided, parallel story. 
Concerning Pop-Up Stores, these would be located in places such as airports and train 
stations, as well as city centers, locations which are highly frequented by young 
professionals on the go. The group displayed how the interior would be laid out, 
including blueprints, 3D simulations and “traffic-generation mirrors” – mirrors in the 
bathroom of airports and train stations with the message: “Stressed hair? Come and visit 
us at the Vichy stand for a free head massage!”.  
Regarding the In-Pharmacy Experience, new eye catching windows and stand-alone 
units were created to still reflect the two-sided story. Furthermore a tablet in those units, 
that is already present at Vichy’s partner pharmacies, would give customers the 
possibility to complete a quiz, which the group created in order to understand what is 
the adequate product of the Dercos category for each individual consumer, granting 
personalized service to clients and ensuring the best probability of customer retention. 
Finally, the Mobile App was the solution that the group found in order to drive 
customer engagement with the product category. Most Vichy online channels are 
heavily underused by consumers (i.e. blog, website, MyIdealSkin, etc.) and the ones 
which are used are extremely tough to control and may have negative effects on the 
product and brand (i.e. Facebook). Therefore, a closed environment such as an app 
would be ideal for Vichy, constituting an added value for consumers and hopefully 
Figure 2 – Outdoor Advertising with Two Sided Story – Men and Women versions 




increasing their willingness to pay for products of the Dercos category. The Dercos app 
would help in motivating customers to finish their three months treatment, in engaging 
them through additional features such as health or diet tips, in supporting customers by 
providing them with a communication platform to get in touch with other customers, 
pharmacists or L’Oréal experts and in supporting pharmacists through the possibility of 
tracking individual consumer behavior. 
If all of the abovementioned measures are implemented, the group is certain that the 
momentum of the launch campaign will be maximized and that its effects will extend to 
the entire Dercos product line, resulting in a larger sales volume for Dercos in Italy and 
an increase in satisfaction of the customer base.  
d. IMPLEMENTATION AND CONCERNS 
Even though it was outside of the scope of the Business Project, the group decided on a 
timeline of events, to map the implementation of the previously mentioned measures. 
 
Regarding concerns, the first one shared by the group was the launch date. Would an 
August launch be the best timing for this product? Although this campaign would allow 
Vichy to increase the awareness of consumers about its seasonal product, Dercos 
Aminexil Pro, that had a sales spike every year around the Autumn months, it would 
also impact customers at a time when they are more disconnected from their problems 
and their daily lives, spending a lot of their time and money on holidays. Even when 
confronted with this, Vichy was not convinced to back down from their launch date. 
Another concern of this Business Project arose regarding the budgeting of the Launch 
strategy. Although it happened due to the mandate of the Business Project itself, all of 
the measures created for the Launch strategy were only subjected to a test of actual 
feasibility and not weighed against their possible costs. In this sense, the strategy was 
Figure 3 – GANTT chart with main events of the product launch 




created in a “utopic” scenario where there are no budget constraints. Given that the 
more realistic case suggests that there are indeed limits to Vichy’s budget and 
availability to pay, the group decided to come up with a priority list of measures, 
suggesting what is essential for the strategy and what is less important if the budget 
cannot accommodate all of the initiatives.  
Much unlike other L’Oréal products, since Dercos Neogenic only sells in pharmacies, 
the group listed the Pharma Strategy and the In-Pharmacy Experience as the 
fundamental pieces of this strategy. After properly funding these two aspects, Vichy 
should address the Mobile App, given the game-changing possibilities it confers to the 
entire Dercos product line. All other initiatives, regarding the Media campaign, the PR 
Event and the Pop-Up Stores, are at the bottom of the priority list given that these 
activities are mostly focused on increasing brand awareness and have the least direct 
effect on sales. Upon being presented this priority list, managers were still confident 
that it would be possible to implement all discussed initiatives. 
The main shortcoming of the Launch strategy devised was the lack of information 
provided by Vichy to restructure the incentive scheme. Therefore, the recommended 
incentive scheme was built as an add-on to the existing one and without knowing what 
is currently being done. With this said, the presented measures seem to be adequate 
almost independently of the underlying (currently active) pharmacy incentive scheme. 
According to Vichy, all the suggestions made on this are reasonable and of easy 
implementation on top of the existing scheme. 
3. PRODUCT LAUNCH AS AN INVESTMENT OPPORTUNITY 
a. THEORETICAL FRAMEWORK – NPV AND REAL OPTIONS 
Whenever a company identifies an investment opportunity, it calculates the project’s 
Net Present Value, to judge if it is worth pursuing. Much unlike shares or bonds, 
business investment opportunities are not passive investments and its associated cash 
flows can therefore be influenced by managers’ decisions. These decisions can modify 
the projects themselves to take advantage of new opportunities or respond to new 
problems, and impact said cash flows, constituting what is known as a “real option”. 
Hence, calculating only the NPV of that opportunity constitutes an over simplification 
of the business environment. It does not capture uncertainty, which, as John Allen 




Paulos once said, is the only certainty there is. The true value of the business investment 
opportunities is better characterized as the aggregation of the “static” NPV and of the 
real options of modifying the project somewhere along the way. 
These decisions throughout the project are often known as “real” options because they 
refer to tangible assets, as opposed to options as derivatives, referring to financial 
instruments. Some examples of real options are the “option to delay”, “option to 
expand”, “option to abandon”, “option to pursue M&A”, etc.  
These examples can easily be applied to decisions which managers have to make when 
a new product’s innovation and launch is analyzed as being an investment opportunity. 
Depending on the degree of complexity that one wants to give the analysis, multiple 
nodes or decision points can be identified, which are the points in time when managers’ 
choices can affect the project’s cash flows. This degree of complexity must be chosen 
by understanding the trade-off between increasing “generality” and “accuracy” and 
consuming too much time with this analysis, much like what Thorngate’s postulate of 
commensurate complexity says on theories of social behavior. 
b. PRODUCT INNOVATION AND LAUNCH – INVESTMENT TIMELINE 
There are four general stages that must be considered throughout the project, each of 
which with the possibility of having several real options embedded.  
Firstly, in order to have a new product in the market, a company must engage in “New 
Idea Generation”, to come up with ideas that may have sufficient demand in the market 
to justify the investment. In this stage, the investment is small and cash outflows are 
focused on sustaining the operations of the team which is working on the idea 
generation. No cash inflows from this project take place in this phase. 
The second stage can be designated as “Research”. During this phase, scientists and 
researchers test the concept in theoretical terms and uncover how to better translate the 
idea into a minimum viable product that can be marketed. At this point, the cash 
outflows are related to the actual research and are significantly larger than during the 
previous stage. Once again, no cash inflows exist at this point in time. 
Thirdly, a company then proceeds to the “Development” phase, where the researched 
concepts are then tested for practical feasibility and cost feasibility and are given form 
and function, prior to being fully ready to market. Cash outflows are even more relevant 




at this point and include experimentation, analysis and prototyping. In this stage, the 
company still has no sales and, therefore, no cash inflows. 
At last, the project goes into the “Launch” stage. During this period, the company has 
cash outflows which are directly linked to its Launch campaign. Also, the product starts 
selling for the first time and, as a consequence, represents cash inflows for the company. 
The discounted cash inflows for the sale of the product are to outweigh the outflows 
throughout all four stages if the entire project is to have a positive Net Present Value. In 
addition and as mentioned above, real options of abandoning the project or changing it 
must be considered if the project is to be accurately valued. 
All of the four stages can be applied to the product at hand and, with this in mind, it 
becomes easier to map Vichy Dercos Neogenic’s gel-fluid product innovation and 
launch as an investment opportunity with embedded real options. 
c. MAPPING VICHY DERCOS NEOGENIC GEL-FLUID AS AN INVESTMENT  
In order to frame Vichy Dercos Neogenic’s product development and launch as an 
investment decision – or multiple decisions – this Work Project builds around the 
following structure (Kang, 2009):  
 
In terms of numbers however, since Vichy did not want to disclose any information, 
most values used for the computation of the ROA are merely fictional and only 
illustrative of how the reasoning and calculations should be performed. 
Compute Base 
Case PV 
• Use Expected 
Values of price and 
quantity, WACC 
and terminal value 
to get to the FCFs 
and calculate NPV 
at time t=0 
 
• No flexibility 
Model 
Uncertainty 
• Identify uncertainty 
in each stage 
 









•  Backtrack to find 
the value of each 
option at each node 
 
•  Compare said 
values with 
investment required 
and choose the 
alternative with the 





• Use portfolio 
replication 
methodology to 
value the project 
 
• Identify the optimal 
exercise paths for 
the real options 
Figure 4 – ROA process from “Real Option Valuation of Product Innovation” 




i. Compute Base Case PV – No Flexibility 
So as to calculate the Base Case PV, it is necessary to understand that there are two 
different moments to be considered. One moment of investment, within the company, 
when there are only cash outflows and which includes “New Idea Generation”, 
“Research” and “Development”. These cash flows must be discounted by using the risk-
free rate since only the time value of money needs to be accounted for. In this case, a 
risk-free rate benchmark which could be used is the 5Y Italian Government Bonds, 
which has as of June 12
th
 of 2015, a current yield of 0.7%. Even though this may seem 
like a low benchmark, it is a direct consequence of the low interest rates that the 
Eurozone has been subjected to and the most adequate one for the project at hand. For 
this reason and for simplification’s sake, the annual risk-free rate used will be 1%. For 
the purposes of this case, each of the four phases will last 3 months – the risk free rate 
of each quarter being 0.25%. The second moment, after the product launch, is related to 
the market and all the cash flows from it should be discounted at the Weighted Average 
Cost of Capital. In this case, however, the approach was slightly different in the sense 
that all cash flows were discounted at the risk free rate, according to what the author 
displays in the book. A binomial tree approach was then used to account for market 
uncertainty, combined with portfolio replication methodology. 
Another factor which must be portrayed is the possibility of not being able to generate 
new ideas, research or develop anything which is viable. As the phases get by, it 
becomes increasingly probable that a certain phase is successful. For the sake of this 
example, the likelihood of success of each stage in this case can be taken as follows: 
Likelihood of… New Idea Generation Research Development 
Success 0.4 0.5 0.7 
Failure 0.6 0.5 0.3 
 
Also a necessary consideration, one must note that different levels of investment will be 
needed for each phase. This investment is growing phase after phase and must be 
considered when calculating the NPV. In this case, the values used were in million euro. 
Table 1 – Likelihood of technological transfer success/failure 

















As a further note, the 4 million euro “Launch” investment is a rough estimate of the cost 
of the Launch strategy which is outlined above, plus the cost of manufacturing.  
Then, it is required to calculate the PV of sales, after the “Launch”. For Vichy Dercos 
Neogenic, it can be assumed to be 30 million euro, even though once again the lack of 
information makes it very difficult to even test if this is a realistic number. Then, the 
NPV of the total project without flexibility must be calculated. 
In this case, the NPV of the total project without flexibility is: 













This equals 22.24 million euro of NPV of the total project without flexibility. Looking 
strictly at this, without including uncertainty and the real options that show managers’ 
flexibility, Vichy should go ahead with the project.  
ii. Model Uncertainty  
Kang then identifies in his book, two sources of uncertainty, linked to the product 
innovation process (Kang, 2009). The first one is technological uncertainty. It is 
assumed to be completely uncorrelated with market conditions, in this case, and 
decreases as the stages go by – see Table 1 – since more time spent researching and 
developing leads to diminished technological uncertainty. In every product innovation 
process, there is the possibility that the technology or concept at hand becomes unviable 
during “New Idea Generation”, “Research” or “Development”, as opposed to being 
successfully transferred to the next stage. If it fails to be transferred, the entire project 
must be terminated and no cash inflows are to be received from said project. If it 
succeeds in a certain phase, it goes on to the next one. On the other hand, product or 
market uncertainty is strictly tied to market conditions and it decreases with time, as the 
real demand for that product or technology becomes known. This source of uncertainty 
Graph 3 – Necessary investment per stage 




includes demand – price and quantity – uncertainty, costs uncertainty, competitors’ 
moves, macroeconomic conditions, etc. In order to quantify all this uncertainty, one can 
resort to historical data – assuming that the past can explain the future to some extent – 
or use subjective estimates provided by management. In the case of Vichy, since it is 
not possible to use historical data, the only solution is to make an educated guess. In the 
example, it is assumed that the expected cashflows after product launch can fluctuate up 
or down by 10% in a quarter due to overall product and market uncertainty. 
 
Having the PV event tree for the product and market uncertainty and the event tree for 
technological uncertainty for the Vichy case, it is now possible to start incorporating 
managerial flexibilities in the calculations. As a side note, it would be possible to 
estimate the volatility of this project and use a standard binomial model to generate the 
event tree. However, as Kang points out, in the case of technological uncertainty, since 
it does not follow a standard Brownian motion process and instead it gets significantly 
resolved at certain points in time, the best way to illustrate this is to keep the sources of 
uncertainty separate and to model their individual impact on the project’s PV explicitly. 
iii. Incorporate Managerial Flexibilities – Real Options 
Upon building the necessary event trees, one must try to identify which managerial 
decisions can have an impact on the project’s cashflows and overall value and at what 
point in time can these decisions take place.  
Firstly, there is clearly the “option to delay” this investment. As in most projects, it is 
possible to delay it until more information becomes available. However, this may not be 
















Figure 5 – PV event tree for product or market uncertainty 




technology and would then enjoy a first-mover advantage. The second managerial 
flexibility is related to technological uncertainty and is an “option to abandon” if the 
technology is not successfully transferred to the following stage. The third managerial 
flexibility is the “option to expand”. If the “Development” stage is successful, Vichy 
has the “option to expand” and to launch the product into the market. It could be argued 
that at every stage, Vichy is confronted with an “option to expand” vs an “option to 
abandon”, with the exercise prices of the earlier being the necessary investment at each 
stage. After identifying these flexibilities, it is now possible to work the trees backwards 
in order to discover the NPV of each decision node. First, looking at technological 
uncertainty: 
 
The NPV in node D was computed by discounting the base case NPV (30 million euro) 
with the quarterly risk-free rate (0.25%) and then subtracting the investment of that 
particular phase (4 million euro). To compute the NPV at node C, one just needs to 
multiply the NPV at node D by the probability of success of “Development” (0.7), 
discount it one quarter and then subtract the 2 million euro investment for that stage. 
Working backwards, it is possible to arrive at an NPV with flexibility of 2.31 million 
euro. Given that the NPV without technological uncertainty or flexibility was 22.24 
million euro, the value decreases by 19.93 due to the technological uncertainty impact. 
Going on to product and market uncertainty, taking Figure 5 as the tree diagram for the 
underlying asset of this project – the PV of sales of Vichy Dercos Neogenic – one can 












Figure 6 – Diagram to value project with technological uncertainty 





By using the parameters on the table, it was possible to construct the diagram with the 
value of the option at each node. It was first necessary to determine the strike price at 
time T in order to obtain the payoffs in the latter stage of the tree. This was done by 
summing the future values of each investment that Vichy has to do for the product to be 
launched. Then this value was subtracted of the expected PVs. Upon getting these 
payoffs, the risk adjusted probability was calculated using u, d and the risk free rate of 
0.25% per quarter. Then, to obtain the option value at time t=0, it was necessary to work 
backwards on the tree, always weighing the possible future payoffs with the risk 
adjusted probabilities and discounting these values appropriately. The result is that, at 
time t=0, this project is worth 22.54 million euro. As a side note, this binomial tree 
assumes that the technology transfer is successful at every stage, since it only models 
product and market uncertainty. 
iv. Calculate Real Option Value 
In the final step of the process, it is then possible to incorporate both sources of 
uncertainty and all managerial flexibilities to come up with an aggregate decision tree, 
allowing for a more accurate valuation of the real option at hand. Once again, this 




u  1.1 
d  0.909 
T  Entire Project Time 0.75 
n Periods 3 
t Time-Step 0.25 
q  Risk-Adjusted Probability 0.49 
















Figure 7 – Binomial tree to value project with product and market flexibility 




A B C D E F G 
 
Node column G represents the cash inflow from product sales that Vichy will receive in 
case the product launch is successful, represented by a positive cash inflow, or in case it 
is a failure, no cash inflows. The values for the successful cases are those that were 
estimated in Figure 5, shown here with two decimals. Column F was computed by 
multiplying the probability of a successful technology transfer (0.7) times the payoff of 
the successful case (39.93, for example) net of the strike price of the launch stage (4) 
and discounted with the risk free rate for half a quarter (0.125%) since the diagram has 
two node columns per quarter. The result of this equation is 25.12.  
For node column E, replicating portfolios of the underlying asset and a risk-free security 
were built (Antikarov, 2001) to value the outcomes that are resolved from market 
uncertainty in the cases where “Development” stage was successful. For all others, the 
NPV at that node is 0 and the project is abandoned.  
2)        𝑚 =
(25.12 − 20.27)
(27.95 − 23.10)
= 0.999          ;         𝐵 =




=  −2.793  
The parameter m is obtained by dividing the results of node F by the corresponding 
values of the PV event tree multiplied by the success rate of the “Development” stage 
Figure 8 – Valuing the project accounting for uncertainties and real options 




(adjusted  PV event tree), as shown by the author. And the B parameter is calculated by 
sorting out what position in risk free assets should one take to get a payoff of 25.12 
when holding a 0.999 position on the underlying asset worth 27.95. By applying these 
parameters to 25.41, the corresponding value of the adjusted PV event tree, and 
subtracting the investment of the “Development” phase, one gets to the value of 20.58.  
Repeating the procedure of discounting expected values of technological uncertainty to 
uncover node columns D and B and of building replicating portfolios based on the 
adjusted PV event tree to value nodes under C and A, it is possible to arrive at the value 
of 2.34 million euro as the value of the entire project including all managerial 
flexibilities and accounting for technological and product or market uncertainties. Given 
this result, Vichy should choose to go ahead with the project at every moment in time, 
as long as the technological transfer is successful. 
As a final note, one can see that this result is strikingly similar to that of the NPV with 
flexibility on technological uncertainty. This is once again a proof that technological 
uncertainty is much more relevant – given the assumptions at hand – and therefore 
anchors the value of the option. 
d. CURRENT SITUATION AND INVESTMENT DECISION 
Nowadays, Vichy finds itself in the decision node column F, in the moment just prior to 
product launch and, implying that the data assumed somehow reflects the reality faced 
by the company, Vichy should go ahead with the product launch since all the NPV’s of 
that column are positive.  
In doing so, Vichy will hopefully leverage on some of the ideas presented in the context 
of the Business Project and do its best to maximize the PV of sales of the new Vichy 
Dercos Neogenic gel-fluid product. 
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